4D Molecular Therapeutics
FDMT
FDMT
151 hedge funds and large institutions have $402M invested in 4D Molecular Therapeutics in 2025 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 56 increasing their positions, 37 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
14% more funds holding
Funds holding: 133 → 151 (+18)
8.83% more ownership
Funds ownership: 84.68% → 93.51% (+8.8%)
Holders
151
Holding in Top 10
–
Calls
$1.13M
Puts
$275K
Top Buyers
| 1 | +$29.2M | |
| 2 | +$18.1M | |
| 3 | +$16.7M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$15.6M |
| 5 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$11.1M |
Top Sellers
| 1 | -$10.7M | |
| 2 | -$3.73M | |
| 3 | -$2.78M | |
| 4 |
JP Morgan Chase
New York
|
-$2.37M |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$1.72M |
